Home/Blog/Low MOQ Supplement Manufacturing in Europe: The Complete Guide
Manufacturing · 10 min read

Low MOQ Supplement Manufacturing in Europe: The Complete Guide

What MOQ really means in EU supplement manufacturing, why floors exist, typical 500–2,000 unit low-MOQ runs by format, lead times and how to actually negotiate.

Low MOQ is the single biggest unlock for new supplement brands in Europe. Five years ago a launch order under 5,000 units was almost impossible to place with a serious GMP-certified manufacturer. In 2026, low-MOQ specialist contract manufacturers across the EU will quote runs of 500–2,000 units for capsules and tablets, 3,000–5,000 for powders and softgels, and 5,000+ for gummies. This guide explains what MOQ actually is, why floors exist, where the real low-MOQ pool lives, and how to negotiate inside it.

What "MOQ" really means

MOQ, minimum order quantity, is the smallest production run a contract manufacturer (CMO) will accept for one SKU. It is not a price quote, not a contract term, and not negotiable in isolation. It is the floor at which the CMO can run the SKU without losing money on the line.

MOQ is also format-specific, not brand-wide. The same manufacturer can quote 1,500 capsules and refuse anything under 25,000 gummies, because the equipment economics are entirely different.

Typical vs low MOQ in 2026, by format

FormatLow-MOQ floorStandard MOQSweet-spot run
Capsules / tablets1,0005,000–10,00025,000+
Softgels3,00010,000–25,00050,000+
Powder (jars)5003,000–10,00025,000+
Powder (sachets / sticks)5,00025,000+100,000+
Gummies5,00025,000–50,000100,000+
Liquid shots2,00010,000–25,00050,000+
Bulk powder25 kg200–500 kg1,000+ kg

Why MOQ floors exist

Every supplement production run has roughly the same fixed setup, regardless of size: line clean-down, raw material weighing and dispensing, in-process quality control, finished-batch testing (identity, potency, microbiology, heavy metals), batch documentation, and packaging line changeover. A 1,000-bottle run absorbs all of that across 1,000 units; a 50,000-bottle run amortises it almost away. Below a certain unit count, the CMO loses money or earns less than the alternative use of the line.

Low-MOQ specialist CMOs exist because they have built their facilities around faster changeovers, smaller batch sizes, and a different cost structure. They charge more per unit and earn it back on volume of small runs rather than depth of large ones.

Why low MOQ matters for new brands

  1. Capital risk. A 1,500-unit run is 3,000–6,000 EUR in inventory. A 25,000-unit run is 35,000–70,000 EUR. If the SKU does not sell, the gap between those two numbers is your runway.
  2. SKU validation. You can test three SKUs at 1,500 units each for less cash than one SKU at 10,000 units, and learn faster which one earns the marketing budget.
  3. Cash conversion. Smaller runs sell through faster, which keeps cash in the business and not on a 3PL pallet.
  4. Iteration speed. Formulation tweaks, dose changes, flavour variants, all cheaper to test in 1,500-unit batches.

Format-by-format reality

  • Capsules and tablets are the easiest format to run low-MOQ. Most low-MOQ EU CMOs lead with this. Two-piece vegan HPMC capsules at 1,000–2,000 units are routinely quoted.
  • Softgels need oil-filling equipment and gelatin handling, so true low-MOQ is rarer. 3,000 units is achievable; below that you are usually stuck with stock white-label.
  • Powders in jars are the lowest-MOQ format overall (500 jars is real). Sachets and sticks jump to 5,000+ because of the form-fill-seal equipment.
  • Gummies remain the hardest low-MOQ category. Mould plates and depositor changeovers are expensive. Below 5,000 units you are mostly on white-label stock SKUs with your label.
  • Liquids and shots sit in the middle: 2,000–5,000 units is achievable, but glass packaging MOQs (usually 5,000+ from the bottle supplier) often dominate the floor.

Lead times at low MOQ

Low-MOQ runs are not faster, sometimes they are slower, because small jobs queue between large ones. Plan for:

  • Stock white-label with your label only: 3–6 weeks.
  • Stock formulation with custom artwork on stock packaging: 5–8 weeks.
  • Lightly modified private label (different dose, added ingredient): 10–14 weeks.
  • Custom formulation at low MOQ (rare): 16–22 weeks plus stability testing.

How to actually negotiate inside the low-MOQ pool

  1. Lead with the stack, not the MOQ. "1,500 units of one SKU" is a weak ask. "1,500 units each of three SKUs on the same magnesium base" is the same line time and a real conversation.
  2. Use stock packaging. Custom bottle moulds, custom dropper caps, and custom sachet designs each carry their own MOQ floor, often higher than the product itself. Stock packaging with custom artwork is the unlock.
  3. Accept the per-unit premium. A low-MOQ CMO that quotes 30–60% over the 25k price is fair. One that quotes 2x is either overloaded or not really a low-MOQ shop.
  4. Commit to a re-order trigger. "If we hit 80% sell-through by week 8, we re-order at 5,000." That gives the CMO a planning signal worth discounting against.

Where the low-MOQ pool actually lives

Low-MOQ supplement CMOs almost never rank on Google. They do not need to, they fill capacity through brokers, distributors, and word of mouth among brand operators. This is the gap Jake fills: he keeps the working list of EU low-MOQ specialists by format, MOQ, and category, and sends pre-vetted intros within a day.

FAQ

What counts as 'low MOQ' for supplement manufacturing in Europe in 2026?

Low MOQ in 2026 typically means 500–2,000 units for capsules and tablets on a stock formulation, 3,000–5,000 for softgels and powders, and 5,000–10,000 for gummies and liquids. Anything below those numbers is achievable only on white-label stock with existing packaging.

Why is per-unit cost so much higher at low MOQ?

Every batch carries the same setup cost, line cleaning, raw material weighing, in-process QC, finished-batch testing, and documentation. A 1,000-unit batch absorbs all of that across 1,000 units, so per-unit cost is usually 30–80% higher than at 5,000 units and 2–3x higher than at 25,000.

Can I get a custom formulation at low MOQ?

Rarely below 5,000 units. Custom formulation also adds 4,000–12,000 EUR in R&D and stability testing, which only makes sense to amortise over a larger run. For launch, almost everyone is better off on a stock or lightly modified private-label formula.

Which EU countries are best for low-MOQ supplement manufacturing?

Italy and Spain have the deepest pool of low-MOQ capsule and tablet manufacturers. Poland and Slovenia are strong for low-MOQ powders. Germany generally starts higher (5,000+) but with very tight quality. The Netherlands is strong for premium softgels at low MOQ.

Skip the search. Let Jake do the sourcing.

Tell Jake what you're building, format, ingredients, target MOQ, market. You get 2–4 pre-vetted EU suppliers with real offers, usually within a business day. Free.

Sourcing something? Tell Jake what you need.

Free to message. Verified EU suppliers. Real offers within a day.